Editor - Zhong-Xing Jiang | Wuhan University | 14818
ISSN: 2329-9053

Journal of Molecular Pharmaceutics & Organic Process Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Zhong-Xing Jiang

Zhong-Xing Jiang
Zhong-Xing Jiang
Department of Pharmaceutical Sciences
Wuhan University
Tel: 86-153-915-622-17
Fax: 86-276-875-9850
Read Interview session with Zhong-Xing Jiang
Wuhan University


Zhong-Xing Jiang was born in Chengdu (China) in 1975. He received his BS in chemistry at the Southwest Normal University (China) in 1999 and received his PhD at the Shanghai Institute of Organic Chemistry (Chinese Academy of Sciences) in 2004. After postdoctoral training with Y. B. Yu at the University of Utah in 2004-2007 and with Z-Y Zhang at the Indiana University in 2007-2008, he moved to the University of Maryland Baltimore as Research Associate then Research Assistant Professor from 2008 to 2011. Since 2011, he has been Professor at the Wuhan University (China). His research is focused on the field of imaging-guided drug delivery system, with a focus on fluorinated biomaterials.

Research Interest

Fundamentally, his interest in science revolves developing novel imaging-guided drug delivery system for both diagnosis and therapy. Historically, he has used organic synthesis and MRI to pursue this interest and recently, this has led him to synthesis of novel fluorinated polymers and drug conjugates as imaging tracers for drug delivery as well as using fluorinated drug to probe small molecule-nuclear receptor interaction. Additionally, the study of structure-function relationships of small molecular antagonist for orphan nuclear receptor as pertains to human health have been investigated by the laboratory using combinatorial synthesis, fluorous chemistry, mass spectrometry and 19F MRI/NMR. All of these efforts are supported by his background in organic synthesis, fluorine chemistry, medicinal chemistry, pharmaceutical chemistry, chemical biology and magnetic resonance imaging. The discovery based science projects within the laboratory are used to generate novel imaging-guided nanomedince for personalized drug therapy.



Global Speakers in the subject

Global Experts in the subject